Table 2.
Univariate analysis of primary and secondary outcomes.
| TC levels ⩽130 mg/dl at Baseline | TC levels 130–200 mg/dl at Baseline | TC levels ⩾200 mg/dl at Baseline | p Value | |
|---|---|---|---|---|
| N = 3372 (9.5%) | N = 8203 (23.2%) | N = 23,739 (67.3%) | ||
| Primary outcomes | ||||
| Any PH at 24 h | 215 (6.8%) | 502 (6.5) | 1374 (6.1%) | 0.238 |
| Moderate and severe CED at 24 h | 250 (8.1%) | 564 (7.5%) | 1321 (6%) | <0.001 |
| Secondary outcomes | ||||
| SICH SITS-MOST | 38 (1.2%) | 88 (1.2%) | 258 (1.2%) | 0.960 |
| SICH ECASS | 126 (4.1%) | 290 (3.9%) | 751 (3.4%) | 0.057 |
| SICH NINDS | 192 (6.2%) | 447 (5.9%) | 1133 (5.1%) | 0.004 |
| PH 2 at 24 h | 70 (2.1%) | 170 (2.1%) | 459 (1.9%) | 0.675 |
| Any cerebral edema at 24 h | 612 (19.7%) | 1426 (18.9%) | 3177 (14.3%) | <0.001 |
| Severe CED at 24 h | 111 (3.6%) | 233 (3%) | 657 (3%) | 0.161 |
| mRS 0–2 at days | 1487 (58.5%) | 3591 (58.7%) | 10,084 (58.4%) | 0.974 |
| mRS 0–1 at days | 1140 (44.8%) | 2778 (45.4%) | 7642 (44.5%) | 0.446 |
| Death at 90 days | 358 (10.6%) | 856 (10.4%) | 2722 (11.5%) | 0.022 |